AC Immune (ACIU) Depreciation and Depletion (2014 - 2025)

AC Immune (ACIU) has 12 years of Depreciation and Depletion data on file, last reported at -$3.1 million in Q4 2025.

• On a quarterly basis, Depreciation and Depletion fell 845.56% year-over-year to -$3.1 million in Q4 2025; TTM through Dec 2025 was -$1.8 million, a 206.07% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 0.89% from the prior year.
• Depreciation and Depletion for Q4 2025 stood at -$3.1 million, down from $425037.2 in the prior quarter.
• Over the last five years, Depreciation and Depletion for ACIU reached as high as $539118.9 in Q3 2021 and fell as low as -$3.1 million in Q4 2025.
• Historically, Depreciation and Depletion has averaged $285687.3 across 5 years, with a median of $452536.6 in 2022.
• Across the five-year window, Depreciation and Depletion soared 37.14% in 2021 and plunged 845.56% in 2025, its largest moves.
• Year by year, Depreciation and Depletion stood at $527068.0 in 2021, then slipped by 9.01% to $479566.1 in 2022, then decreased by 1.97% to $470106.8 in 2023, then slipped by 12.83% to $409806.3 in 2024, then plunged by 845.56% to -$3.1 million in 2025.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were -$3.1 million in Q4 2025, $425037.2 in Q3 2025, and $438464.2 in Q2 2025.